Get the tools used by (smart)2 investors.

Market Cap / LTM Revenue for Novartis AG ADR

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

NVS: Novartis AG ADR

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

111.48 USD
Price
USD
Fair Value
Upside
92.35 - 120.92
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Novartis AG ADR's Market Cap / LTM Revenue:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0x1.0x2.0x3.0x4.0x5.0x

Performance Summary
  • Novartis AG ADR's latest twelve months market cap / ltm revenue is 4.1x
  • Novartis AG ADR's market cap / ltm revenue for fiscal years ending December 2020 to 2024 averaged 4.2x.
  • Novartis AG ADR's operated at median market cap / ltm revenue of 4.2x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Novartis AG ADR's market cap / ltm revenue peaked in December 2023 at 4.5x.
  • Novartis AG ADR's market cap / ltm revenue hit its 5-year low in December 2021 of 3.8x.
  • Novartis AG ADR's market cap / ltm revenue decreased in 2020 (4.3x, -3.6%), 2021 (3.8x, -13.3%), and 2024 (4.1x, -10.3%) and increased in 2022 (4.2x, +12.5%) and 2023 (4.5x, +7.0%).

How does Novartis ADR's Market Cap / LTM Revenue benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Novartis AG ADR because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Market Cap / LTM Revenue

Hide this widget
market_to_revenue_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Market Cap / LTM Revenue in the valuation category include:

  • Price / NNWC - Compares the current stock price to the Net Net Working Capital (NNWC) where NNWC equals Cash & Equivalents + (Accounts Receivables x 0.75) + (Inventory x 0.5) - Total Liabilities.
  • Price / Sales Growth Ratio - A heuristic used to measure the level of revenue growth relative to the Price / Sales multiple.
  • Shares Outstanding CAGR (5y) - Five-year compound annual growth rate in shares outstanding.
  • EV / Fwd EBIT - Measures the dollars in Enterprise Value for each dollar of EBIT projected to be earned over the next twelve months.
View Full List

Search for metric or datapoint

Market Cap / LTM Revenue

Indicates the multiple of revenue that stock investors are willing to pay for one share of the firm.

Definition of Market Cap / LTM Revenue

Hide this widget

Market Cap / LTM Revenue also known as Price / Sales, or P/S ratio is a financial ratio that compares a company’s market capitalization to the amount of revenue the company earned during the last 12 months.

P/S Ratio = Market Cap / LTM Revenue

Applying this formula, Novartis’s P/S Ratio is calculated below:

Market Capitalization [ $209.9 B ]
(/) Revenue [ $51.722 B ]
(=) P/S Ratio [ 4.1x ]

Equivalently, it can also be calculated by dividing the per-share stock price by the per-share projected revenue.

The tables below summarizes the trend in Novartis’s P/S Ratio over the last five years:

Date Market Cap Revenue P/S Ratio
2020-12-31 $214.9 B $49.584 B 4.3
2021-12-31 $196.9 B $52.385 B 3.8
2022-12-31 $194.5 B $46.017 B 4.2
2023-12-31 $207.4 B $45.85 B 4.5
2024-12-31 $195.4 B $48.157 B 4.1

Read more about the ratio on Wikipedia, sales and market capitalization.


Click the link below to download a spreadsheet with an example Market Cap / LTM Revenue calculation for Novartis AG ADR below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
27.1x327.1x627.1x1,165.0x020406080

The chart above depicts the distribution of market cap / ltm revenue for companies operating in the Healthcare sector in the Developed economic region. Over 1,950 companies were considered in this analysis, and 1,881 had meaningful values. The average market cap / ltm revenue of companies in the sector is 27.6x with a standard deviation of 99.1x.

Novartis AG ADR's Market Cap / LTM Revenue of 4.1x ranks in the 59.1% percentile for the sector. The following table provides additional summary stats:

Market Cap / LTM Revenue In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,959
Included Constituents1,881
Min0.0x
Max1,141.9x
Median2.7x
Mean27.6x
Standard Deviation99.1x

You can find companies with similar market cap / ltm revenue using this stock screener.

All rights reserved. Terms Of Use